| Completed | Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | 2019-03-06 |
| Completed | Study of Parkinson's Early Stage With Deferiprone Parkinson's Disease | Phase 2 | 2016-10-12 |
| Completed | Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Voluntee Healthy | Phase 1 | 2015-06-01 |
| Completed | Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects Asymptomatic HIV Infection | Phase 1 | 2015-06-01 |
| Terminated | Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anem Iron Overload, Sickle Cell Disease, Other Anemias | Phase 4 | 2015-05-21 |
| Completed | Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers Healthy | Phase 1 | 2015-05-01 |
| Completed | Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration Pantothenate Kinase-Associated Neurodegeneration | Phase 3 | 2014-06-01 |
| Completed | Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers Healthy | Phase 1 | 2014-05-01 |
| Terminated | Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Iron Overload, Sickle Cell Disease, Other Anemias | Phase 4 | 2014-04-17 |
| Completed | A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferipr Healthy Volunteers | Phase 1 | 2013-11-01 |
| Completed | Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 1 | 2013-05-01 |
| Completed | An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency a Hepatic Impairment | Phase 4 | 2013-01-01 |
| Completed | An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impai Renal Impairment | Phase 4 | 2013-01-01 |
| Completed | Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PK Pantothenate Kinase-Associated Neurodegeneration | Phase 3 | 2012-12-13 |
| Completed | Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects Prolonged QTc Interval | Phase 4 | 2012-11-01 |
| Completed | Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2011-11-01 |
| Completed | Active Drug Surveillance Program of Ferriprox Use Transfusional Iron Overload | — | 2010-06-01 |
| Completed | A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia Friedreich's Ataxia | Phase 2 | 2009-06-01 |
| Completed | A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia Friedreich's Ataxia | Phase 1 / Phase 2 | 2008-04-01 |
| Completed | Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients Iron Overload | Phase 3 | 2007-08-01 |
| Completed | Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infecte HIV Infection | Phase 1 | 2006-11-01 |
| Terminated | Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers Diabetic Foot Ulcer | Phase 3 | 2006-02-01 |
| Completed | Efficacy Study in Removing Excess Iron From the Heart Thalassemia Major, Hemosiderosis | Phase 4 | 2002-12-01 |